Hannover Re (FRA:HNR1) has been given a €122.00 ($141.86) price objective by equities researchers at Royal Bank of Canada in a report issued on Thursday. The brokerage presently has a “neutral” rating on the stock. Royal Bank of Canada’s price objective points to a potential downside of 2.63% from the stock’s previous close.
A number of other research firms also recently weighed in on HNR1. Commerzbank set a €112.00 ($130.23) price objective on Hannover Re and gave the company a “neutral” rating in a report on Thursday, August 9th. DZ Bank restated a “buy” rating on shares of Hannover Re in a report on Thursday, August 9th. Barclays set a €106.00 ($123.26) price objective on Hannover Re and gave the company a “sell” rating in a report on Monday, August 6th. Jefferies Financial Group set a €109.00 ($126.74) price objective on Hannover Re and gave the company a “neutral” rating in a report on Friday, August 3rd. Finally, JPMorgan Chase & Co. set a €108.00 ($125.58) price objective on Hannover Re and gave the company a “neutral” rating in a report on Wednesday, July 18th. Five analysts have rated the stock with a sell rating and seventeen have issued a hold rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of €112.87 ($131.24).
Shares of HNR1 opened at €125.30 ($145.70) on Thursday. Hannover Re has a 52 week low of €94.75 ($110.17) and a 52 week high of €116.37 ($135.31).
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Recommended Story: Technical Analysis of Stocks and What It Means
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.